A serum biomarker panel for early detection of treatment-related cardiotoxicity in early HER2-positive breast cancer patients
The interaction between both hs-Tn I and hs-CRP demonstrates significant predictive value for cardiotoxicity risk related to HER2+ breast cancer treatment.
Authors
- Wiaam M Hasan
- Zuheir Alshehabi (ORCID: https://orcid.org/0000-0002-6519-7954)
- Haider Abbas (ORCID: https://orcid.org/0009-0000-9629-6333)
- Nadeem Ahmed (ORCID: https://orcid.org/0000-0002-3574-4275)
- Faisal Redwan
- Ahmed A. Ahmed (ORCID: https://orcid.org/0000-0002-0409-7589)
Institutions
- Latakia University (SY)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1097/ms9.0000000000004191
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00